MedPath
TGA Approval

BORTEZOMIB HETERO bortezomib 3.5 mg powder for injection vial (214243)

214243

BORTEZOMIB HETERO bortezomib 3.5 mg powder for injection vial

Hetero Australia Pty Ltd

August 5, 2021

Medicine

Medicine

Active

Registered

Active Ingredients

bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BORTEZOMIB HETERO bortezomib 3.5 mg powder for injection vial (214243) - TGA 批准文号 | MedPath